GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $259,000 | +16.1% | 8,205 | +6.5% | 0.10% | +8.3% |
| Q3 2016 | $223,000 | -61.6% | 7,705 | -67.2% | 0.10% | -61.4% |
| Q1 2016 | $581,000 | +8.6% | 23,470 | +54.5% | 0.25% | +10.2% |
| Q4 2015 | $535,000 | -30.6% | 15,193 | -58.3% | 0.23% | -34.9% |
| Q3 2015 | $771,000 | -23.4% | 36,438 | +0.6% | 0.35% | -15.6% |
| Q2 2015 | $1,007,000 | +55.9% | 36,213 | +71.4% | 0.41% | +56.3% |
| Q1 2015 | $646,000 | +4.2% | 21,130 | +9.1% | 0.26% | +10.0% |
| Q4 2014 | $620,000 | -19.4% | 19,375 | -28.7% | 0.24% | -19.3% |
| Q3 2014 | $769,000 | -5.8% | 27,180 | -8.7% | 0.30% | -3.9% |
| Q2 2014 | $816,000 | +7.8% | 29,775 | +3.6% | 0.31% | -1.9% |
| Q1 2014 | $757,000 | +33.7% | 28,750 | +48.7% | 0.31% | +38.3% |
| Q4 2013 | $566,000 | -0.7% | 19,340 | +3.8% | 0.23% | -12.0% |
| Q3 2013 | $570,000 | +45.4% | 18,640 | +50.7% | 0.26% | +41.0% |
| Q2 2013 | $392,000 | – | 12,365 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
| Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
| Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
| Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
| Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
| Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
| CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
| Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |